Answers are grounded in this paper and cite their sources.
BackgroundInfantile tremor syndrome (ITS) presents with nutritional, neurological, developmental, and hematological abnormalities in infancy.The diagnostic performance of serum homocysteine and its relationship with different clinical presentations across the ITS spectrum remain insufficiently characterized.This study aimed to evaluate the diagnostic performance of serum homocysteine and compare it with serum vitamin B12 in children with ITS/pre-ITS. MethodsThis observational unmatched case-control study was conducted in the Department of Pediatrics of Gandhi Medical College over 19 months.Forty children with ITS/pre-ITS and 40 apparently healthy controls were enrolled.Serum homocysteine, vitamin B12, folate, electrolytes, and hematological parameters were assessed.Between-group comparisons and receiver operating characteristic (ROC) curve analyses were performed to evaluate the diagnostic performance of serum homocysteine and vitamin B12. ResultsSerum homocysteine was significantly higher in cases than controls (median {interquartile range, IQR}: 35.70 {30.53-42.92}versus 5.52 {4.70-6.20}µmol/L; p < 0.001).ROC analysis demonstrated excellent apparent discrimination for serum homocysteine (area under the curve {AUC}, 0.995; 95% confidence interval {CI}, 0.987-1.000),with 100% sensitivity and 92.5% specificity at an exploratory ROC-derived threshold of ≥19.2 µmol/L.Serum vitamin B12 showed substantially lower discrimination (AUC, 0.604; 95% CI, 0.464-0.744).Homocysteine concentrations were significantly higher in children with ITS than in those with pre-ITS (41.61 ± 9.64 versus 32.82 ± 8.05 µmol/L; p = 0.003). ConclusionSerum homocysteine demonstrated greater apparent case-control discrimination than vitamin B12 among children with ITS/pre-ITS.However, substantial nutritional differences between cases and healthy controls may have inflated the observed diagnostic performance.The exploratory ROC-derived threshold of ≥19.2 µmol/L requires independent validation in clinically representative populations before routine clinical application.
No takes yet. Share an insight, caveat, or question.
Goel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: